Status:
COMPLETED
Effects of Soft Tissue Lengthening on Gait in Children With Spasticity
Lead Sponsor:
University of Texas Southwestern Medical Center
Conditions:
Muscle Spasticity
Eligibility:
All Genders
4-21 years
Brief Summary
This research project is being conducted to investigate changes in secondary impairments, functional mobility skills, and gait variables in children with spasticity following selective percutaneous my...
Eligibility Criteria
Inclusion
- Scheduled for an selective percutaneous myofascial lengthening procedure,
- Between the ages of 4.0 and 20.11 years old,
- Lower extremity spasticity,
- Able to ambulate 50 feet without a rest, with or without an assistive device, and with or without ankle foot orthoses (AFOs) and
- Able to follow one step directions.
Exclusion
- Botox injections into any lower extremity muscle within three months of the scheduled selective percutaneous myofascial lengthening procedure,
- Lower extremity orthopedic surgery within 6 months of the scheduled selective percutaneous myofascial lengthening procedure,
- Visual impairment that interferes with maintaining a straight path while ambulating,
- Uncontrolled seizure disorder
- A change in medication that affects spasticity or ability to follow one step directions within three months of the scheduled selective percutaneous myofascial lengthening procedure.
Key Trial Info
Start Date :
May 10 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 31 2017
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT04090892
Start Date
May 10 2016
End Date
January 31 2017
Last Update
September 16 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Medical Center
Dallas, Texas, United States, 75390